ICER Lays Out GLP-1 Access Options In Addition To Medicare Coverage

By Luke Zarzecki / April 9, 2025 at 5:35 PM

The Institute for Clinical and Economic Review (ICER) published a white paper laying out several ways to make GLP-1 obesity medications more affordable, coming as CMS coverage was nixed by the Trump administration Friday (April 4).

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

ICER Lays Out GLP-1 Access Options In Addition To Medicare Coverage

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.